4D Molecular Therapeutics
Uneek Mehra serves as the Chief Financial and Business Officer at 4D Molecular Therapeutics since September 2023, following a similar role at Myovant Sciences from September 2021 to July 2023. Prior positions include Chief Financial Officer at PACT Pharma, where personalized tumor-mutation targeted T cells are developed, and Executive Vice President & Chief Financial Officer at Proteus Digital Health, Inc., which focuses on integrating digital health solutions. At Novartis, Uneek Mehra held various senior roles including Global Head of Portfolio Management, Licensing and M&A in Oncology and Group Head of Financial Planning & Analysis. Educational credentials include an MBA in Leadership & Business Strategy from IMD and an MBA in Finance & Systems from the University of Mumbai, along with a Bachelor's degree in Electronics from Birla Institute of Technology and Science, Pilani.
4D Molecular Therapeutics
6 followers
4D Molecular Therapeutics designs develop and commercialize transformative gene therapy products for serious unmet medical conditions.